e-Drug3D

906

ESZOPICLONE


INN
ESZOPICLONE

cas 138729-47-2
CLASS

NERVOUS SYSTEM
HYPNOTICS AND SEDATIVES
GABA RECEPTOR AGONIST

ROUTE (list)

ORAL

ATC code

N05CF04

PK parameters

Tmax 1 HOUR
PPB 56 PERCENT
t1/2 6 HOUR

Solubility

VERY SLIGHTLY SOLUBLE IN WATER


Target

TARGET GABA RECEPTOR

DrugCentral

Gamma-aminobutyric acid receptor subunit alpha-2 UNIPROT P47869 GABRA2

Gamma-aminobutyric acid receptor subunit alpha-4 UNIPROT P48169 GABRA4

Download SDF file [(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate

Formula:
C17H17ClN6O3

Calculated chemical properties:

MW 388.82
NB_atoms 27
XLogP 1.57
PSA 79.793
NB_HD 0
NB_HA 9
fsp3 0.35
Lipinski(0=no;1=yes) 1

FDA
NDA 021476 (pdf not found) INN (ESZOPICLONE) LUNESTA (WAYLIS THERAP) APPROVAL= AP YEAR= 2004
NDA 091124 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (LUPIN LTD) APPROVAL= AP YEAR= 2011
NDA 091169 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (TEVA) APPROVAL= AP YEAR= 2011
NDA 091165 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (CHARTWELL RX) APPROVAL= AP YEAR= 2011 DISCONTINUED
NDA 091151 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (MYLAN PHARMS INC) APPROVAL= AP YEAR= 2013
NDA 091103 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (SUN PHARM) APPROVAL= AP YEAR= 2013
NDA 091166 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (GLENMARK PHARMS LTD) APPROVAL= AP YEAR= 2014
NDA 091113 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (ORBION PHARMS) APPROVAL= AP YEAR= 2014
NDA 091024 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (DR REDDYS) APPROVAL= AP YEAR= 2014
NDA 091153 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (HIKMA) APPROVAL= AP YEAR= 2014 DISCONTINUED
NDA 202929 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (MACLEODS PHARMS LTD) APPROVAL= AP YEAR= 2015
NDA 208451 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2016
NDA 203087 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (AVIV PHARMA) APPROVAL= AP YEAR= 2019 DISCONTINUED
NDA 206222 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (IPCA LABS LTD) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 205504 (pdf not found) INN (ESZOPICLONE) ESZOPICLONE (HETERO LABS LTD V) APPROVAL= AP YEAR= 2024

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL